214 related articles for article (PubMed ID: 3084761)
1. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Breedon TH; Bennett BM; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):608-14. PubMed ID: 3084761
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
3. The role of nitric oxide formation in organic nitrate-induced vasodilation and organic nitrate tolerance.
Marks GS; Nakatsu K; McLaughlin B; Kawamoto J; Slack C; Brien JF
Z Kardiol; 1989; 78 Suppl 2():18-21; discussion 64-7. PubMed ID: 2555978
[TBL] [Abstract][Full Text] [Related]
4. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
Torfgård KE; Ahlner J; Axelsson KL; Norlander B; Bertler A
Drug Metab Dispos; 1992; 20(4):553-8. PubMed ID: 1356734
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relaxation of aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
Eur J Pharmacol; 1992 Jan; 211(1):129-32. PubMed ID: 1618261
[TBL] [Abstract][Full Text] [Related]
8. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide formation from glyceryl trinitrate by rabbit aortic strip: detection by rabbit taenia coli concurrent with vasorelaxation.
Hussain AS; Poklewska-Koziell M; Brien JF; Marks GS; Nakatsu K
Br J Pharmacol; 1994 Dec; 113(4):1508-14. PubMed ID: 7889309
[TBL] [Abstract][Full Text] [Related]
10. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.
DiFabio J; Ji Y; Vasiliou V; Thatcher GR; Bennett BM
Mol Pharmacol; 2003 Nov; 64(5):1109-16. PubMed ID: 14573760
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
J Pharmacol Exp Ther; 1993 Mar; 264(3):1432-9. PubMed ID: 8450477
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
13. Requirement for reduced, unliganded hemoprotein for the hemoglobin- and myoglobin-mediated biotransformation of glyceryl trinitrate.
Bennett BM; Kobus SM; Brien JF; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):629-35. PubMed ID: 3084763
[TBL] [Abstract][Full Text] [Related]
14. Superoxide does not inhibit glyceryl trinitrate-rabbit aortic strip-mediated relaxation of rabbit Taenia coli. Evidence against a role for nitric oxide itself as the smooth muscle active drug metabolite?
Hussain AS; Brien JF; Marks GS; Nakatsu K
Drug Metab Dispos; 1996 Jul; 24(7):780-5. PubMed ID: 8818576
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 1994 Nov; 271(2):708-14. PubMed ID: 7965786
[TBL] [Abstract][Full Text] [Related]
16. Relationship between biotransformation of glyceryl trinitrate and cyclic GMP accumulation in various cultured cell lines.
Bennett BM; Leitman DC; Schröder H; Kawamoto JH; Nakatsu K; Murad F
J Pharmacol Exp Ther; 1989 Jul; 250(1):316-23. PubMed ID: 2545862
[TBL] [Abstract][Full Text] [Related]
17. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
18. Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.
Marks GS; McLaughlin BE; MacMillan HF; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1989 May; 67(5):417-22. PubMed ID: 2504466
[TBL] [Abstract][Full Text] [Related]
19. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate.
Kearney MF; Brien JF; Marks GS; Lei H; Nakatsu K
Drug Metab Dispos; 1998 Jun; 26(6):547-51. PubMed ID: 9616190
[TBL] [Abstract][Full Text] [Related]
20. Effect of temperature on glyceryl trinitrate induced relaxation of rabbit aorta.
Booth BP; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1993 Aug; 71(8):629-32. PubMed ID: 8306203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
